Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 540

1.
2.
4.

beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi.

Baillie GS, Sood A, McPhee I, Gall I, Perry SJ, Lefkowitz RJ, Houslay MD.

Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):940-5. Epub 2003 Jan 27.

6.

Functional coupling of adenosine A2a receptor to inhibition of the mitogen-activated protein kinase cascade in Chinese hamster ovary cells.

Hirano D, Aoki Y, Ogasawara H, Kodama H, Waga I, Sakanaka C, Shimizu T, Nakamura M.

Biochem J. 1996 May 15;316 ( Pt 1):81-6.

7.

Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine.

Hein TW, Wang W, Zoghi B, Muthuchamy M, Kuo L.

J Mol Cell Cardiol. 2001 Feb;33(2):271-82.

PMID:
11162132
8.
10.

Signaling via A2A adenosine receptor in four PC12 cell clones.

Arslan G, Kull B, Fredholm BB.

Naunyn Schmiedebergs Arch Pharmacol. 1999 Jan;359(1):28-32.

PMID:
9933147
11.

Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation.

Eckly-Michel A, Martin V, Lugnier C.

Br J Pharmacol. 1997 Sep;122(1):158-64.

12.
13.

Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.

Zhu B, Kelly J, Vemavarapu L, Thompson WJ, Strada SJ.

Biochem Pharmacol. 2004 Aug 1;68(3):479-91.

PMID:
15242814
14.
15.

Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.

Rose RJ, Liu H, Palmer D, Maurice DH.

Br J Pharmacol. 1997 Sep;122(2):233-40.

17.

Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.

Link AA, Kino T, Worth JA, McGuire JL, Crane ML, Chrousos GP, Wilder RL, Elenkov IJ.

J Immunol. 2000 Jan 1;164(1):436-42.

18.

Inhibition of voltage-sensitive calcium channels by the A2A adenosine receptor in PC12 cells.

Park TJ, Chung S, Han MK, Kim UH, Kim KT.

J Neurochem. 1998 Sep;71(3):1251-60.

19.

Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.

Whalin ME, Scammell JG, Strada SJ, Thompson WJ.

Mol Pharmacol. 1991 Jun;39(6):711-7.

PMID:
1646946
20.

Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors.

Liu S, Veilleux A, Zhang L, Young A, Kwok E, Laliberté F, Chung C, Tota MR, Dubé D, Friesen RW, Huang Z.

J Pharmacol Exp Ther. 2005 Aug;314(2):846-54. Epub 2005 May 18.

Items per page

Supplemental Content

Write to the Help Desk